ArticlePalliative medicine reports2025
Association Between Antibiotic Withdrawal and End-of-Life Comfort in Patients with Advanced Cancer and Suspected Infections: A Multicenter Retrospective Cohort Study.
Article in Palliative medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The role of palliative care in addressing end-of-life needs and enhancing the comfort of patients with life-threatening illnesses is crucial. This study aimed to evaluate the relationship between antibiotic withdrawal and end-of-life discomfort in patients with terminal cancer with suspected infections. Materials and Methods: A multicenter retrospective cohort study was conducted on patients aged ≥18 years with advanced cancer and life expectancy under six weeks, as determined by a Palliative Prognostic Index >4. Patients were admitted between January 2018 and December 2021, received antibiotics for suspected infections, and died during hospitalization. Patients were categorized into two cohorts based on whether antibiotic therapy was withdrawn or continued within 72-120 hours prior to death. Data were collected through medical chart review. End-of-life comfort was assessed using the validated Edmonton Comfort Assessment Form scale, with scores ≥4 indicating discomfort. Multivariate logistic regression was used to evaluate the association between antibiotic withdrawal and end-of-life discomfort. Results: A total of 187 patients were included, with a median age of 71 years; 81.8% had solid tumors, predominantly of gastrointestinal origin. Respiratory tract infections were the most common, and sepsis was present in 13% of cases. Symptoms remained mild in both groups, though pain was higher in the antibiotic withdrawal group (median score: 4 vs. 3). Multivariate analysis revealed no significant association between antibiotic withdrawal and end-of-life discomfort (odds ratio = 0.98; 95% confidence interval = 0.52-1.84). Conclusions: Symptom management for pain, nausea, and dyspnea was generally effective, though moderate pain persisted in some patients after antibiotic withdrawal. Antibiotic withdrawal was not associated with increased discomfort at the end of life. These findings support aligning antibiotic decisions with comfort-focused goals in palliative care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.